Germany
Japan
United Kingdom
China
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
| Applications | Bl, FC, IP |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Antibodies
View as table DownloadRecombinant Anti-CD64 (Clone H22)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD80 (Clone IDEC-114 (Galiximab))
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
| Applications | ELISA, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone 5D12)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human, Monkey, Cynomolgus |
| Conjugation | Unconjugated |
Recombinant Anti-desmosome/hemidesmosome (Clone F12)
| Applications | IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Fas (Clone R-125224)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Rhesus D antigen (Clone D7C2)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
| Applications | ELISA, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD80 (Clone 16C10)
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-BRD4 (Clone RAB-C131)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-CBX5 (Clone RAB-C133)
| Applications | ChIP, ELISA |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-CBX1 (Clone RAB-C145)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-PRMT5 (Clone RAB-C136)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-WDR5 (Clone RAB-C223)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-CBX2 (Clone RAB-C238)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-L3MBTL1 (Clone RAB-C213)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-PRDM4 (Clone RAB-C367)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-PRDM9 (Clone RAB-C370)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-PRMT3 (Clone RAB-C372)
| Applications | ChIP, ELISA |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-SETD7 (Clone RAB-C220)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-SFMBT1 (Clone RAB-C396)
| Applications | ChIP, ELISA |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-TDRD3 (Clone RAB-C419)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-SUV420H2 (Clone RAB-C409)
| Applications | ChIP, ELISA |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-FOXP4 (Clone RAB-S40)
| Applications | ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-FOXP1 (Clone RAB-S37)
| Applications | ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-FOXP2 (Clone RAB-S249)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-PD-L1 (Clone 332M7)
| Applications | FC |
| Reactivities | Human, Monkey, Mouse |
| Conjugation | Unconjugated |
USD 420.00
4 Weeks
USD 420.00
4 Weeks
USD 420.00
4 Weeks
USD 420.00
4 Weeks
Active filters
Reactivities
- Human
Antibody Hosts
- Human
Filter by
Target Symbol
- CD274 (11)
- MYC (5)
- EGFR (4)
- TNF (3)
- CD80 (2)
- FN1 (2)
- IL2RA (2)
- BRD4 (1)
- CBX1 (1)
- CBX2 (1)
- CBX5 (1)
- CD22 (1)
- CD33 (1)
- CD38 (1)
- CD4 (1)
- CD40 (1)
- CD40LG (1)
- CD52 (1)
- CD70 (1)
- CEA (1)
- DESMOSOME/HEMIDESMOSOME (1)
- EPHA2 (1)
- ERBB2 (1)
- FAS (1)
- FCGR1A (1)
- FOXP1 (1)
- FOXP2 (1)
- FOXP4 (1)
- GM2 (1)
- IL6R (1)
- ITGA2B (1)
- ITGA4 (1)
- ITGA5 (1)
- ITGAL (1)
- KMT5C (1)
- L3MBTL1 (1)
- MS4A1 (1)
- PRDM4 (1)
- PRDM9 (1)
- PRMT3 (1)
- PRMT5 (1)
- RHD (1)
- SETD7 (1)
- SFMBT1 (1)
- TDRD3 (1)
- TNFSF4 (1)
- TYRP1 (1)
- VEGFA (1)
- WDR5 (1)
Isotypes
Clonalities
Conjugates
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (13)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)